Peptide drug conjugates (PDCs) represent a groundbreaking approach in targeted therapy, offering a powerful strategy for treating diseases, particularly cancer. Peptide drug conjugates are a class of biopharmaceuticals that combine a therapeutic peptide with a cytotoxic or biologically active drug. The peptide serves as a targeting moiety, enabling the conjugate to selectively bind to specific receptors or biomarkers on the surface of target cells, such as cancer cells.
Once the peptide binds to its receptor, the conjugated drug is delivered directly into the target cell, where it exerts its therapeutic action. The conjugation of peptides with drugs is typica...
